The proprietary
Microcyn® Technology Platform is capable of producing
a pH-neutral, non-irritating solution of oxychlorine
compounds that are similar to the chemicals produced
by the human body (neutrophils) in its defense against
microorganisms. The mechanism of action of oxychlorine
compounds against single-cell organisms, due to their
reactivity with lipids and proteins in cell membranes,
can cause these organisms to rupture and die. It
has been reported that Microcyn induces vasodialation
and has demonstrated biocompatibility with fibroblast
and granulation tissue.
The Microcyn Technology is capable of producing a
highly controlled blend of oxychlorine chemicals specially
formulated to demonstrate activity against a wide range
of microorganisms at exceedingly low concentrations. It
is also this controlled balance of chemicals that is
responsible for the technology’s extended stability,
tissue biocompatibility, efficacy and safety. |
